$19 Billion USD Needed for ACT-Accelerator

Financing the ACT-Accelerator in 2021 costs less than 1% of what governments are spending on stimulus packages

The Access to COVID-19 Tools ACT-Accelerator is a global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines. It was set up in response to a call from G20 leaders in March 2020 and launched by WHO, European Commission, France, and the Bill & Melinda Gates Foundation on 24 April 2020.

The ACT-Accelerator, the global alliance to accelerate development of vaccines, therapeutics and diagnostics tools to contain the COVID-19 pandemic released a report today that takes stock of the success achieved, and identifies the funding gap.

To date $14 billion USD have been donated to ACT-Accelerator, and a further funding of $19 billion USD is needed.

“We can only end the pandemic by funding, sharing, and scaling-up access to the tools we need to fight the disease.” WHO Director-General Dr Tedros Adhanom

Major advances in scientific discoveries have been made in the last year, the report says, showing a new level of coordination, a…